Charles Schwab Investment Management »

Taysha Gene Therapies shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $930k 463k 2.01
2024-06-30 $963k 430k 2.24
2024-03-31 $148k 52k 2.87
2023-12-31 $29k 16k 1.77
2023-09-30 $51k 16k 3.16
2023-06-30 $11k 16k 0.66
2023-03-31 $13k 16k 0.80
2022-12-31 $37k 16k 2.26
2022-09-30 $32k 16k 1.98
2022-06-30 $338k 91k 3.73
2022-03-31 $1.1M 165k 6.53
2021-12-31 $1.9M 163k 11.65
2021-09-30 $2.9M 158k 18.62
2021-06-30 $1.8M 87k 21.21
2021-03-31 $1.2M 58k 20.31
2020-12-31 $1.4M 52k 26.55